IMRN vs GILD: Which Stock is Better?
Side-by-side comparison of Immuron Ltd and Gilead Sciences Inc in 2026
IMRN
Immuron Ltd
$0.85
GILD
Gilead Sciences Inc
$140.45
Key Metrics Comparison
| Metric | IMRN | GILD | Winner |
|---|---|---|---|
| Market Cap | $8.69M | $174.33B | GILD |
| P/E Ratio | N/A | 20.72 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | IMRN |
| Gross Margin | 63.7% | 78.8% | GILD |
Analyze IMRN
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMRN or GILD a better investment?
Comparing IMRN and GILD: Immuron Ltd has a market cap of $8.69M while Gilead Sciences Inc has $174.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMRN and GILD?
IMRN (Immuron Ltd) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMRN or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMRN or GILD?
IMRN has higher revenue growth at 0.0% vs 0.0% for GILD.
Which company is more profitable: IMRN or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 63.7% for IMRN.
Which is the larger company: IMRN or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $174.33B compared to $8.69M for IMRN.
Should I buy IMRN or GILD in 2026?
Both IMRN and GILD have investment merit. IMRN trades at $0.85 while GILD trades at $140.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMRN and GILD stock?
Key differences: Market Cap ($8.69M vs $174.33B), P/E Ratio (N/A vs 20.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (63.7% vs 78.8%).